Brain reserve and the clinical expression of Alzheimer's disease
- PMID: 9307589
Brain reserve and the clinical expression of Alzheimer's disease
Abstract
Prospective clinicopathologic studies show that a large proportion of older, nondemented individuals have sufficient numbers of plaques and tangles to meet neuropathologic criteria for Alzheimer's disease (AD). One explanation for this finding is that these individuals had greater brain reserve, which buffered clinical expression of the disease. Three types of brain reserve are discussed: (1) the number of neurons and/or the density of their interconnections in youth, (2) the collection of cognitive strategies for solving problems and taking neuropsychological tests, and (3) the amount of functional brain tissue remaining at any age. Evidence is presented showing that brain reserve reduces clinical expression of AD and can be altered through several means, including early-life nutrition, prevention of cerebrovascular disease and intellectual stimulation.
Similar articles
-
Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality.Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):113-22. Neuropsychiatry Neuropsychol Behav Neurol. 2002. PMID: 12050474
-
Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.Neurobiol Aging. 2005 Mar;26(3):341-7. doi: 10.1016/j.neurobiolaging.2004.06.019. Neurobiol Aging. 2005. PMID: 15639312
-
Intracranial volume in mild cognitive impairment, Alzheimer's disease and vascular dementia: evidence for brain reserve?Int J Geriatr Psychiatry. 2004 Oct;19(10):995-1007. doi: 10.1002/gps.1205. Int J Geriatr Psychiatry. 2004. PMID: 15449362
-
Pathophysiology of neuronal energy crisis in Alzheimer's disease.Neurodegener Dis. 2008;5(3-4):126-32. doi: 10.1159/000113681. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322369 Review.
-
Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.Methods Find Exp Clin Pharmacol. 2007 Jul;29 Suppl A:1-91. Methods Find Exp Clin Pharmacol. 2007. PMID: 17957277 Review.
Cited by
-
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.J Alzheimers Dis. 2016;52(3):1055-64. doi: 10.3233/JAD-150478. J Alzheimers Dis. 2016. PMID: 27104893 Free PMC article.
-
Traumatic brain injury as a risk factor for Alzheimer's disease: a review.Neuropsychol Rev. 2000 Jun;10(2):115-29. doi: 10.1023/a:1009068804787. Neuropsychol Rev. 2000. PMID: 10937919 Review.
-
The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments.PLoS One. 2018 Jan 29;13(1):e0190615. doi: 10.1371/journal.pone.0190615. eCollection 2018. PLoS One. 2018. PMID: 29377891 Free PMC article.
-
Lifelong bilingualism and neural reserve against Alzheimer's disease: a review of findings and potential mechanisms.Behav Brain Res. 2015 Mar 15;281:9-15. doi: 10.1016/j.bbr.2014.12.006. Epub 2014 Dec 8. Behav Brain Res. 2015. PMID: 25496781 Free PMC article. Review.
-
Decreasing mental frailty in at-risk elders.Geriatr Nurs. 1998 Jul-Aug;19(4):220-4. doi: 10.1016/s0197-4572(98)90156-2. Geriatr Nurs. 1998. PMID: 9866512 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical